Effect of Reduced Angiotensin-Converting Enzyme Gene Expression and Angiotensin-Converting Enzyme Inhibition on Angiotensin and Bradykinin Peptide Levels in Mice

Hypertension

Volumn 43, Issue 4, 2004, Pages 854-859

  Campbell, Duncan J ^a,d   Alexiou, Theodora ^a   Xiao, Hong D ^b   Fuchs, Sebastien ^b   McKinley, Michael J ^a   Corvol, Pierre ^c   Bernstein, Kenneth E ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c l'alimentation et l'Environnement   (France)

^d ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Angiotensin I; Angiotensin II; Angiotensin converting enzyme; Bradykinin; Mice

Indexed keywords

ANGIOTENSIN; BRADYKININ; BRADYKININ DERIVATIVE; BRADYKININ[1-7]; BRADYKININ[1-9]; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; UNCLASSIFIED DRUG;

ADOLESCENT; ADRENAL GLAND; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; GENETIC MODEL; HEART; KIDNEY; KNOCKOUT MOUSE; LUNG; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN METABOLISM; TISSUE LEVEL;

ADRENAL GLANDS; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BRADYKININ; BRAIN; ENZYME INDUCTION; FEMALE; KIDNEY; LISINOPRIL; LUNG; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIUM; ORGAN SPECIFICITY; PEPTIDE FRAGMENTS; PEPTIDYL-DIPEPTIDASE A;

EID: 1642501567     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000119190.06968.f1     Document Type: Article

References (22)

1. Dell'Italia LJ, Husain A. Dissecting the role of chymase in angiotensin II formation and heart and blood vessel diseases. Curr Opin Cardiol. 2002;17:374-379.
2. Wei CC, Tian B, Perry G, Meng QC, Chen YF, Oparil S, Dell'Italia LJ. Differential ANG II generation in plasma and tissue of mice with decreased expression of the ACE gene. Am J Physiol. 2002;282:H2254-H2258.
3. Campbell DJ, Kladis A, Duncan A-M. Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides. Hypertension. 1994;23:439-449.
4. Campbell DJ, Duncan A-M, Kladis A. Angiotensin converting enzyme inhibition modifies angiotensin, but not kinin peptide levels in human atrial tissue. Hypertension. 1999;34:171-175.
5. Zeitz CJ, Campbell DJ, Horowitz JD. Myocardial uptake and biochemical and hemodynamic effects of ACE inhibitors in humans. Hypertension. 2003;41:482-487.
6. Nussberger J, Brunner DB, Waeber B, Brunner HR. True versus immunoreactive angiotensin II in human plasma. Hypertension. 1985;7:I-1-I-7.
7. Mazzolai L, Pedrazzini T, Nicoud F, Gabbiani G, Brunner HR, Nussberger J. Increased cardiac angiotensin II levels induce right and left ventricular hypertrophy in normotensive mice. Hypertension. 2000;35:985-991.
8. Esther CR, Jr., Howard TE, Marino EM, Goddard JM, Capecchi MR, Bernstein KE. Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility. Lab Invest. 1996;74:953-965.
9. Campbell DJ, Lawrence AC, Kladis A, Duncan A-M. Strategies for measurement of angiotensin and bradykinin peptides and their metabolites in central nervous system and other tissues. In: Smith AI, ed. Methods in Neurosciences, volume 23: Peptidases and Neuropeptide Processing. Orlando: Academic Press; 1995:328-343.
10. Dell'Italia LJ, Meng QC, Balcells E, Wei CC, Palmer R, Hageman GR, Durand J, Hankes GH, Oparil S. Compartmentalization of angiotensin II generation in the dog heart - Evidence for independent mechanisms in intravascular and interstitial spaces. J Clin Invest. 1997;100:253-258.
11. Meng QC, Durand J, Chen Y-F, Oparil S. Simplified method for quantitation of angiotensin peptides in tissue. J Chromatogr Biomed Appl. 1993;614:19-25.
12. Lawrence AC, Clarke IJ, Campbell DJ. Angiotensin peptides in brain and pituitary of rat and sheep. J Neuroendocrinol. 1992;4:237-244.
13. Senanayake PD, Moriguchi A, Kumagai H, Ganten D, Ferrario CM, Brosnihan KB. Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats. Peptides. 1994;15:919-926.
14. Dell'Italia LJ, Balcells E, Meng QC, Su XF, Schultz D, Bishop SP, Machida N, Straeter-Knowlen IM, Hankes GH, Dillon R, Cartee RE, Oparil S. Volume-overload cardiac hypertrophy is unaffected by ACE inhibitor treatment in dogs. Am J Physiol. 1997;273:H961-H970.
15. Dell'Italia LJ, Meng QC, Balcells E, Straeter-Knowlen IM, Hankes GH, Dillon R, Cartee ER, Orr R, Bishop SP, Oparil S, Elton TS. Increased ACE and chymase-like activity in cardiac tissue of dogs with chronic mitral regurgitation. Am J Physiol. 1995;269:H2065-H2073.
16. Schuijt MP, van Kats JP, de Zeeuw S, Duncker DJ, Verdouw PD, Schalekamp MA, Danser AH. Cardiac interstitial fluid levels of angiotensin I and II in the pig. J Hypertens. 1999;17:1885-1891.
17. Kokkonen JO, Saarinen J, Kovanen PT. Regulation of local angiotensin II formation in the human heart in the presence of interstitial fluid - Inhibition of chymase by protease inhibitors of interstitial fluid and of angiotensin-converting enzyme by Ang-(1-9) formed by heart carboxypeptidase A-like activity. Circulation. 1997;95:1455-1463.
18. Campbell DJ, Aggarwal A, Esler M, Kaye D. β-blockers, angiotensin II, and ACE inhibitors in patients with heart failure. Lancet. 2001;358:1609-1610.
19. 12] angiotensin I in human dorsal hand veins: in vivo demonstration of non-ACE production of angiotensin II in humans. Circulation. 2001;104:1805-1808.
20. Jorde UP, Ennezat PV, Lisker J, Suryadevara V, Infeld J, Cukon S, Hammer A, Sonnenblick EH, Le Jemtel TH. Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure. Circulation. 2000;101:844-846.
21. Weaver D, Skinner S, Walker L, Sangster M. Phenotypic inhibition of the renin-angiotensin system, emergence of the Ren-2 gene, and adaptive radiation of mice. Gen Comp Endocrinol. 1991;83:306-315.
22. Mazzolai L, Nussberger J, Aubert JF, Brunner DB, Gabbiani G, Brunner HR, Pedrazzini T. Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system. Hypertension. 1998;31:1324-1330.